SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-018148
Filing Date
2022-11-22
Accepted
2022-11-22 16:10:34
Documents
14
Period of Report
2022-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20221122x8k.htm   iXBRL 8-K 36854
2 EX-99.1 aytu-20221122xex99d1.htm EX-99.1 10491
3 GRAPHIC aytu-20221122xex99d1001.jpg GRAPHIC 4381
  Complete submission text file 0001558370-22-018148.txt   177544

Data Files

Seq Description Document Type Size
4 EX-101.SCH aytu-20221122.xsd EX-101.SCH 3131
5 EX-101.LAB aytu-20221122_lab.xml EX-101.LAB 15903
6 EX-101.PRE aytu-20221122_pre.xml EX-101.PRE 10060
8 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20221122x8k_htm.xml XML 4914
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 221410434
SIC: 2834 Pharmaceutical Preparations